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Abstract Different methods for snap freezing surgical
human tissue specimens exist. At pathology institutes with
higher work loads, solid carbon dioxide, freezing sprays,
and cryostat freezing are commonly used as coolants for
diagnosing frozen tissue sections, whereas for tissue
banking, liquid nitrogen or isopentane cooled with liquid
nitrogen is preferred. Freezing tissues for diagnostic and
research purposes are therefore often time consuming,
laborious, even hazardous, and not user friendly. In tissue
banks, frozen tissue samples are stored in cryovials,
capsules, cryomolds, or cryocassettes. Tissues are addition-
ally embedded using freezing media or wrapped in plastic
bags or aluminum foils to prevent desiccation. The latter
method aggravates enormously further tissue handling and
processing. Here, we describe an isopentane-based work-
flow which concurrently facilitates tissue freezing and
processing for both routine intra-operative frozen section
and tissue banking and satisfies the qualitative demands of
pathologists, cancer researchers, laboratory technicians, and
tissue bankers.
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Introduction
The use of modern technologies in genomics and proteomics
permits the identification of disease-associated mechanisms
at molecular levels. Research data are mostly derived from
cell lines or animal models. To translate this knowledge into
clinical applications, it is necessary to examine numerous,
well-documented human tissues of high quality. Tissue
collections appropriate for such investigations exist, partic-
ularly in pathology institutes at universities.
For diagnostic purposes, tissue samples are generally
treated in two ways. Almost all specimens are formalin
fixed and paraffin embedded (FFPE). This procedure is
routinely used for hematoxylin staining and immunohisto-
chemical analysis of tissue sections cut from paraffin
blocks. For rapid intra-operative sections, tissue samples
are generally directly placed onto a metal chuck provided
with optimal cutting temperature (OCT) compound and
frozen either using solid carbon dioxide or the cooling
chamber of a cryostat [8]. Slow freezing of tissues produces
artifacts due to aggregation of water molecules into ice
crystals, which is significantly reduced with liquid nitrogen
[8, 11]. Because of the very low temperature of liquid
nitrogen, extremely soft tissues, such as brain, spleen, or
lymph node, become brittle and rigid and therefore are
difficult to cut. In addition, liquid nitrogen evaporates
rapidly particularly in small containers, which consequently
have to be refilled several times a day.
As FFPE tissue is of limited quality for molecular
analyses [12], additional tissue pieces are also kept frozen
for future diagnostic and research purposes in many
pathology institutes at universities. However, as with rapid
sectioning, the protocols designed for freezing tissues for
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tissue banks commonly differ and are not always standard-
ized. For tissue banking, “superfluous” tissue pieces not
needed for diagnostic purposes are commonly frozen in
liquid nitrogen or in cooled isopentane. Different strategies
are applied to preserve tissue specimens for tissue banks.
Cold-resistant cryovials or cryomolds are commonly used
because they can be labeled easily and do not require much
space [1, 2, 6]. Freezing medium is also added to protect
tissue pieces from desiccation. Alternatively, tissue samples
can also be wrapped in plastic bags or aluminum foils [1, 3].
Sometimes tissues were brought into shape depending on the
size of the containers/tissue cassettes. All these methods are
disadvantageous as tissues are difficult to handle for further
processing. Snap-frozen, non-embedded tissues pieces are
also transferred directly into plastic bags, which are placed in
a box containing numerous other plastic bags with different
tissue samples. The storage of a growing number of plastic
bags in a cryocontainer may hamper determining the location
of the tissues of interest and thus becomes, as the tissue
collection may grow rapidly, more and more unmanageable.
An additional important and critical issue of tissue banking is
that in most of the cases the quality of the morphology of
stored frozen tissue is unknown. Consequently, there is no
guarantee for which purposes/methods the collected tissues
may ideally be used for research projects.
Here, we describe a protocol that is applicable to both
rapid intra-operative section and tumor tissue banking. The
effects of solid carbon dioxide, isopentane, and liquid nitro-
gen on tissue morphology and molecular structures (RNA,
DNA, and protein) of tumor tissues embedded in OCT are
also discussed.
Materials and methods
Tissue samples Eleven tumors derived from patients who
underwent surgery (between May and June 2006) at Zurich
University Hospital were randomly selected for this study.
There were one renal cell carcinoma, two breast carcino-
mas, three lung carcinomas, one endometrial carcinoma,
one stomach carcinoma, one seminoma, and two ovarian
carcinomas. Three different protocols were applied to test
and compare the effects of different freezing media on the
morphological structure of each of the tumor samples. (a)
For rapid sectioning, macro-dissected tumor material was
frozen using the carbon dioxide quick-freeze method
(carbon dioxide gas), where the coolant flows directly over
the tissue [8]. This procedure has routinely been applied at
our institute for the last two decades. (b) In parallel, one
tissue piece of each of the 11 tumors not further needed for
diagnostic purposes was wrapped in a plastic bag, put into a
cryocassette, and snap frozen in liquid nitrogen for 10 s.
This method has been used for collecting frozen tissues for
our tissue bank since 1992. (c) An additional piece of tissue
from each of the tumors was transferred to a cryocassette
provided with a plastic mold. The tissue in the plastic mold
was covered with OCT compound and snap frozen by
immersing the closed cryocassette in pre-cooled isopentane
at −80°C for 30 s using the mechanic freezer SnapFrost®
(Alphelys, France). HE sections from all frozen tissue
specimens were reviewed by a pathologist (H.M.).
Immunohistochemistry Frozen sections (4 μm) were treated
with acetone (10 min) and then fixed in buffered formalin for
30 min. Following antigen retrieval for 10 min at 96°C in 0.1
M citrate buffer, tissue sections were incubated using MIB-1
(1:20 dilution; DAKO, Glostrup, Denmark). Standard im-
munohistochemical detection of bound antibody was per-
formed using goat anti-rabbit IgG secondary antibodies
followed by the ABC (Vectastain) and peroxidase substrate
kits (1:200 dilution; Vector Laboratories, Burlingame, CA,
USA).
DNA and RNA extraction Ten 20-μm sections were cut
from each of the tumor samples either frozen in liquid
nitrogen at −196°C or in isopentane at −80°C. DNA (five
sections from each tumor) and RNA (five sections from each
tumor) were extracted using the Biorobot EZ1 workstation
(Qiagen) in combination with the recommended kit (EZ1
DNA tissue and EZ1 RNA Universal Tissue, respectively)
according to the instructions of the manufacturer. DNA and
RNA yield and purity was analyzed using a NanoDrop 1000
spectrophotometer. RNA integrity was assessed using the
2100 bioanalyzer (Agilent).
PCR mRNA expression of β-actin was determined in all
isopentane and liquid nitrogen frozen tumors using con-
ventional reverse transcriptase polymerase chain reaction
(RT-PCR). Briefly, 1 μg total RNA was reverse transcribed
using 50 ng of random hexamers, 100 U of M-MLV reverse
transcriptase, and 20 U of RNAse Out (all reagents and
enzymes from Invitrogen) for 10 min at 25°C and 60 min at
37°C. cDNA (2 μl each) was serially diluted (1:50, 1:250,
and 1:500). A 485-bp fragment of β-actin was amplified
using 2 µl GeneAmp® 10× PCR buffer (Applied Bio-
systems), 2 mM MgCl2, 0.5 μM primers (forward primer:
agc ctc gcc ttt gcc ga; reverse primer: gag gcg tac agg gat
agc ac), and 1 U of AmpliTaq Gold® Taq polymerase
(Applied Biosystems). PCR was performed in a total
volume of 20 µl for 10 min at 94°C and 35 cycles with
30 s at 94°C, 30 s at 55°C, and 1 min at 72°C. Fifty
nanograms of genomic DNA of each of the 11 tumors was
used to amplify sequences of exon 1 of the von Hippel
Lindau gene (267 and 503 bp) [7] and the PAX-2 gene (927
bp; forward primer: ggg tac aag acg ccc agt agt agt; reverse
primer: ctt cct tcc tct ctt tct ggt cct).
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Immunoblot Protein was extracted from 20-μm tissue
sections using RIPA buffer (Sigma). Total protein concen-
tration was measured using the bicinchoninic acid protein
assay (Pierce) and NanoDrop 1000 spectrophotometer.
Twenty micrograms of protein of each sample was
separated on NuPage™ 4–12% Bis–Tris gels (Invitrogen)
and transferred to nitrocellulose membrane following
standard protocols. The membrane was incubated for 1
h at room temperature with mouse-monoclonal antibody
against β-actin (1:5,000, MAB1501, Chemikon) in 1% fat-
free dry milk in 1× TBST. HRP-conjugated rabbit anti-
mouse secondary antibody (1:5,000, ab6728, Abcam) was
used to detect β-actin. For signal detection, the ECL™
Western Blotting analysis system in combination with
Hyperfilm™ (Amersham Pharmacia) was used.
Statistics Paired Student’s t tests were applied to assess
significant variances between the DNA, RNA, and protein
values obtained from differentially treated tumors.
Results
Tissue pieces from 11 different tumor tissue specimens
were snap frozen either with carbon dioxide snow, liquid
nitrogen, or isopentane, which was pre-cooled at −80°C
using the mechanical freezer SnapFrost®. The procedure
for the latter method is outlined in Fig. 1a–c. HE sections
were reviewed to study the effects of the three freezing
media on tumor tissue morphology. As demonstrated in
Fig. 2, the carbon dioxide quick-freeze method damaged
the tissue structure due to ice crystal formation. In contrast,
no artifacts were seen in tissues that were frozen in
isopentane or liquid nitrogen. The morphological evalua-
tion and the amounts of RNA, DNA, and protein obtained
from each of the differently treated tumors are listed in
Table 1. Statistical comparison of RNA, DNA, and protein
concentrations showed no significant differences between
tumors frozen in isopentane or liquid nitrogen (Table 2).
Positive results of immunohistochemical, Western blot,
RNA and DNA analyses were obtained from all tumors that
were frozen in liquid nitrogen or isopentane. Examples of
protein, DNA, and RNA data of one seminoma and one
endometrial carcinoma embedded in OCT and frozen in
isopentane are illustrated in Fig. 3.
Discussion
In view of the different procedures used for rapid intra-
operative section and tissue banking in many pathology
institutes, our study aimed at establishing a reliable method
which is applicable to both fields of activity. The use of a
mechanical freezer and isopentane not only improves
significantly the quality of the diagnosis of rapid sections,
but also preserves the cellular and molecular structures of
tumor tissues, which is a requisite for high-quality tissue
banking.
Compared to tissues treated with carbon dioxide gas, the
morphology of the tissues frozen with isopentane and liquid
nitrogen was significantly more homogeneous and repre-
sentative. It also seems obvious that the morphology of
tumor types displaying more complex and irregular
patterns, such as carcinomas of the lung, endometrium,
and kidney, was best preserved with isopentane (Table 1,
Fig. 2b). In contrast to isopentane, which directly transmits
the temperature to the specimen, liquid nitrogen creates a
layer of nitrogen gas around the tissue, which delays the
freezing rate. This may explain our observation that certain
tissues frozen in isopentane retain a slightly better mor-
phology. Accordingly, this method is superior to quick-
freeze procedures commonly used for routine frozen section
examination and clearly facilitates evaluating routine rapid
sections.
Embedding tissues in a frozen tissue matrix, such as
OCT compound (Tissue Tek®), is required for reviewing
properly HE sections from tumors. We used plastic molds
in which tissue pieces of a maximal volume of 20×15×5
mm can be placed and embedded in OCT and which fit
exactly in cryocassettes. Freezing tissues in plastic molds
results in regular-shaped tissue blocks (Fig. 1c). To generate
frozen sections, the OCT tissue block can easily be fixed on
a chuck in a cryostat by gently pressing against the base of
the plastic mold. This procedure has been used for both
rapid section and tissue banking. For the latter method, it is
important to prevent the cut tissue from desiccation. As
OCT protects tissues from the freeze-burn effect of liquid
nitrogen, we re-sealed transparently the tissue surface with
OCT diluted 1:1 with aqua bidest using a brush (Fig. 1d).
The tissue block was then transferred to a mechanically
labeled cryocassette and stored in a cryobox at −80°C for
arranging concisely archived frozen tissue until reuse
(Fig. 1e).
Knowing the histological composition and the quality of
stored tissue is a basic prerequisite for tumor tissue banking
(Fig. 1f). Morphological features, such as tumor area, non-
neoplastic area, and percentage of tumor cells within the
tumor area, are directly documented on the glass slide with
the HE section. This allows tracking precisely those tumor
tissue specimens suited for the molecular method required
for future cancer research projects. For analyzing reliably
gene mutations, gene or protein expression patterns in
tumors, tissue samples used for extractions should prefer-
ably not or only be low contaminated with non-neoplastic
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cells. It is of note, however, that RNA extracted from
tumors with more than 50% tumor cells is apparently still
sufficient for yielding a gene expression signature as
predictor of survival in breast cancer [10]. Very heteroge-
neous tumors, in which the cell population of interest
constitutes only a small fraction, can still be used for in situ
analyses, immunostainings, laser micro-dissection, or PCR-
based microbial DNA/RNA detection.
Fig. 1 Tissue processing for rapid section (a–c) and tumor tissue
banking (a–f). Tumor tissue in plastic mold embedded with OCT (a).
Tissue holder with cryocassette containing tissue prepared for freezing
at −80°C in isopentane using the SnapFrost® (b). Resulting OCT
tissue block (c). Resealing of the cut tissue surface with diluted OCT
(d). Tissue storage (e). Quality control of tumor tissue for biobanking
(f). +/− Good/bad morphology, T tumor, N normal, Necr necrosis, %
tumor cells
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According to the recommendations of the European
Human Frozen Tumour Tissue Bank (TuBaFrost) [5] and
the guidelines for the collection, handling, and storage of
specimens from the Breast International Group (BIG) and
National Cancer Institute (NCI) Cooperative Group breast
cancer clinical trials (http://ctep.cancer.gov/forms/guidelines_
fresh_tissue.pdf), isopentane is the medium of choice for snap
freezing tissues as it is a very efficient cryoconductor and in
comparison to liquid nitrogen, causes fewer cryo-artifacts. In
addition, OCT is an option for tumor biobanking as it gives
high-quality results for histology study, preserves morpholo-
gy by protecting tissue from the lyophilization effect of liquid
nitrogen, and minimizes biological cross contamination.
However, there is hardly any literature data that described
the possible chemical reactions of isopentane and OCT with
cellular structures and its impact on molecular assays. Using a
modified protocol for immunostaining frozen tissue sections
and Western blot, we observed Ki-67 and β-actin expression
patterns that were detectable in all tumor types and virtually
identical between the differently treated tissue pairs. By
Fig. 2 Examples of HE stained sections of a seminoma (a–c) and an endometrial carcinoma (d–f) (magnifications ×10 and ×40). Tissue frozen
with carbon dioxide snow (a, d), isopentane (b, e), and liquid nitrogen (c, f). Arrows indicate artifacts due to ice crystal formation
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comparing the results obtained with liquid nitrogen, we
conclude that IHC and Western results were not influenced
negatively, neither by isopentane nor by OCT.
Previous studies suggested that the presence of OCT in
DNA extracts can inhibit amplification by polymerase
chain reactions [9]. Using a column-based system, which
highly purifies DNA from any residual components, we
were able to amplify DNA fragments ranging from 267 to
927 bp in all tumors. This strongly suggests that a
successful amplification of larger PCR products mainly
depends on the protocol used for extracting DNA from
OCT embedded tumors. It is also of note that there were no
Table 1 The impact of freezing medium on tumor morphology, RNA, DNA, and protein quality








Renal cell carcinoma Isopentane +++ 1.43 2.1 1.5 8.4 0.71 4.32
Liquid nitrogen ++ 1.01 2.08 1.7 8.5 0.56 4.0
CO2 + nd nd nd nd nd nd
Breast carcinoma Isopentane ++ 0.97 2.07 1.2 8.1 0.34 5.4
Liquid nitrogen ++ 8.2 2.06 1.3 8.3 0.42 4.2
CO2 + nd nd nd nd nd nd
Lung adenocarcinoma Isopentane ++ 1.09 2.05 1.2 7.9 0.67 3.8
Liquid nitrogen ++ 1.31 2.08 1.1 7.3 0.59 4.5
CO2 + nd nd nd nd nd nd
Endometrial carcinoma Isopentane +++ 2.46 2.11 1.6 7.4 1.56 5.6
Liquid nitrogen ++ 2.18 2.12 1.7 7.6 1.72 6.8
CO2 + nd nd nd nd nd nd
Stomach carcinoma Isopentane ++ 1.55 2.09 1.4 7.9 0.89 3.9
Liquid nitrogen ++ 2.48 2.1 1.7 7.5 1.47 5.8
CO2 + nd nd nd nd nd nd
Lung adenocarcinoma Isopentane ++ 1.28 2.1 1.4 7.5 0.36 4.1
Liquid nitrogen ++ 0.84 2.07 1.1 7.9 0.29 3.5
CO2 + nd nd nd nd nd nd
Seminoma Isopentane ++ 0.78 2.01 1.3 6.4 0.14 6.0
Liquid nitrogen ++ 0.91 2.04 1.3 6.3 0.16 6.4
CO2 + nd nd nd nd nd nd
Ovarian carcinoma Isopentane ++ 0.81 2.04 1.8 8.3 0.32 3.8
Liquid nitrogen ++ 0.77 2.08 1.6 8.2 0.4 3.6
CO2 + nd nd nd nd nd nd
Ovarian carcinoma Isopentane ++ 1.37 2.09 1.0 7.2 0.96 4.9
Liquid nitrogen ++ 1.35 2.11 1.0 7.3 0.78 4.5
CO2 + nd nd nd nd nd nd
Breast carcinoma Isopentane ++ 0.88 2.11 1.4 8.8 0.56 2.2
Liquid nitrogen ++ 1.23 2.08 1.3 8.5 0.72 3.0
CO2 + nd nd nd nd nd nd
Lung adenocarcinoma Isopentane +++ 0.92 2.07 1.3 7.9 0.7 4.8
Liquid nitrogen ++ 0.57 2.02 1.4 7.9 0.46 4.2
CO2 + nd nd nd nd nd nd
nd Not done
a Evaluation of morphology: + problematic; ++, +++ well evaluable; +++ morphology better than ++
b Total volume: 50 μl
Table 2 Mean values ± standard deviations of RNA, DNA, and protein extracted from tissues frozen in isopentane and liquid nitrogen
Medium RNA (μg/μl) 260/280 nm rRNA ratio RIN DNA (μg/μl) Protein (μg/μl)
Isopentane 1.18+0.54 2.08+0.03 1.41+0.22 7.89+0.47 0.66+0.37 4.44+1.01
Liquid nitrogen 1.15+0.65 2.08+0.03 1.38+0.25 7.85+0.45 0.69+0.46 4.59+1.17
p value ns ns ns ns ns ns
ns Not significant
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significant differences between the freezing media, tumor
types, and DNA yields (Table 1).
Although RNA seems to be stable in non-fixed surgical
specimens for up to 16 h [4], it is widely accepted that
comprehensive gene expression profiling studies rely on
RNA of high quality. To test the integrity of the RNA of
our tissue samples, snap freezing was done as recommen-
ded [5] within 30 min after surgery. As shown in Table 1,
RNA integrity numbers (RIN) were comparable between
the differently treated tumor pairs being highest for one
breast carcinoma (8.8) and lowest for one seminoma (6.3).
RIN, ribosomal RNA ratios, optical density, RNA yields,
and RT-PCR results showed that intact RNA was obtained
from all tumor types (Table 1, Fig. 3e,f) embedded in OCT.
Fig. 3 Examples of protein, DNA, and RNA quality analyses of OCT
embedded tumors frozen in isopentane. Ki-67 stained tissue sections (a,
b). Western blot showing β-actin expression in matched tumors frozen in
liquid nitrogen or isopentane (c). DNA amplification of VHL (267 and
503 bp) and PAX-2 (927 bp) gene fragments (d). Bioanalyzer scans of
extracted total RNA (e). RT-PCR of β-actin mRNA (485 bp) with
diluted cDNA (1:50, 1:250, and 1:500; f). Se Seminoma, En endometrial
carcinoma, N2 liquid nitrogen, Iso isopentane
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Long-term storage of tissue samples is one of the most
challenging issues for tissue banking. As our protocol was
first established in January 2006 at our institute, we
currently do not know whether the integrity of cellular
and molecular structures of our tissues becomes compro-
mised after storage for a longer period of time. By
following strictly the guidelines of TuBaFrost [5], BIG,
and NCI (http://ctep.cancer.gov/forms/guidelines_fresh_
tissue.pdf) for tissue banking, the procedure described here
should ensure the quality of tissue samples. In fact, re-
analysis of the tumor tissues after 1 year of storage at −80°
C demonstrated clearly that the high quality of morphology,
DNA, and RNA remained unchanged (data not shown).
Safety reasons also strongly argue for using a system like
the SnapFrost®. Carbon dioxide originating from liquid
carbonic acid stored in a cylinder is often used for rapid
section. Depending on the type of disease, treating tissues
using this method may cause formation of harmful aerosol,
which may be infectious when inhaled. For tissue banking,
liquid nitrogen is commonly filled in containers that have to
be opened many times for freezing tissues, which causes
strong evaporation. In contrast, isopentane is a non-degass-
ing fluid which is kept in a closable freezing chamber. This
considerably lowers the risks for cold burns and infections.
We developed an isopentane-based protocol that may
help to standardize snap-freezing tissues for both routine
rapid section and tumor biobanking in pathology institutes.
This procedure is time saving, simplifies significantly tissue
handling and processing, and preserves excellently the
integrity of cellular and molecular structures in different
tumor types, thus satisfying the demands of pathologists,
scientists, technicians, and tissue bankers.
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